Evidence map›Paper›PMID 34037832›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2021

Correction to: [

Marta Ferreira, Pierre Lovinfosse, Johanne Hermesse, Marjolein Decuypere, Caroline Rousseau, François Lucia, Ulrike Schick, Caroline Reinhold, Philippe Robin, Mathieu Hatt and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

  • Erratum for
    [2021
5 · Who and what money

Authors and funding

17 authors.

Marta FerreiraGIGA-CRC in vivo Imaging, University of Liège, GIGA, Avenue de l'Hôpital 11, 4000, Liege, Belgium. m.Ferreira@student.uliege.be.
Pierre LovinfosseDivision of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium.
Johanne HermesseDepartment of Radiation Oncology, Liège University Hospital, Liège, Belgium.
Marjolein DecuypereDivision of Oncological Gynecology, University Hospital of Liège, Liège, Belgium.
Caroline RousseauUniversité de Nantes, CNRS, Inserm, CRCINA, F-44000, Nantes, France.
François LuciaRadiation Oncology Department, University Hospital, Brest, France.
Ulrike SchickRadiation Oncology Department, University Hospital, Brest, France.
Caroline ReinholdDepartment of Radiology, McGill University Health Centre (MUHC), Montreal, Canada.
Philippe RobinDepartment of Nuclear Medicine and EA3878, Brest University Hospital, University of Brest, Brest, France.
Mathieu HattLaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
Dimitris VisvikisLaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
Claire BernardDivision of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium.
Ralph T H LeijenaarOncoradiomics SA, Clos Chanmurly 13, 4000, Liège, Belgium.
Frédéric KridelkaDivision of Oncological Gynecology, University Hospital of Liège, Liège, Belgium.
Philippe LambinThe-D Lab, Precision Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands.
Patrick E MeyerBioinformatics and Systems Biology Lab, University of Liège, Liège, Belgium.
Roland HustinxGIGA-CRC in vivo Imaging, University of Liège, GIGA, Avenue de l'Hôpital 11, 4000, Liege, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34037832
PMCPMC8440297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.